No description available.

No description available.

共著者あり。共著者名: Kuniaki Suzuki, Masatake Yoshikawa, Tohru Imai, Akira Matsumotob and Shinji Nakamura. Elsevier Science Ltd., Takashi Kajii, Kuniaki Suzuki, Masatake Yoshikawa, Tohru Imai, Akira Matsumotob and Shinji Nakamura, Long-term effects of prostaglandin E2 on the mineralization of a clonal osteoblastic cell line (MC3T3-E1), Archives of Oral Biology, 44(3), 1999 MAR, pp.233-241. doi:10.1016/S0003-9969(98)00120-4. Journal Website: http://intl.elsevierhealth.com/journals/arob/ / Prostaglandin (PG) E2 is thought to be a mediator of the effect of mechanical stress on bone formation, but its effects on osteoblasts have not yet been fully described. Here, the effects of the continuous application of PGE2 and indomethacin, an inhibitor of prostaglandin G/H synthase (cyclo-oxygenase), on the proliferation, differentiation and mineralization of a clonal osteoblastic cell line, MC3T3-E1, were investigated. The cells were cultured in media with either a high (1 μg/ml) or a low (1 ng/ml) concentration of PGE2, with indomethacin (1 μg/ml) and, as a control, with neither agent. The effects of PGE2 and indomethacin were assessed quantitatively. Indomethacin and a high concentration of PGE2 increased the total protein compared to the control and low-PGE2 cultures. 7 days after confluence, alkaline phosphatase (ALP) activity within the cells and extracellular matrices increased. This increase was highest with indomethacin and lowest with a high concentration of PGE2. ALP activity also increased in the medium, but only 21 days after confluence; the effects of the agents were similar to those on the cells and matrices. The accumulation of calcium, inorganic phosphate and hydroxyproline was highest with indomethacin. PGE2 production was at its maximum when the cells were at confluence and was inhibited by indomethacin. Specific [3H]PGE2 binding to the microsomal fraction of the cell was also measured to examine the expression of the PGE2 receptor. The amount of [3H]PGE2 binding per mg of protein was highest at confluence, then decreased and again increased in the mineralizing stage. These results suggest that indomethacin increases ALP activity and the accumulation of mineralized tissue in MC3T3-E1 cells, presumably by inhibiting the production of PGE2. PGE2 could signal the suppression of mineralization as early as confluence. / Hokkaido University (北海道大学) / 博士 / 歯学

Filamin A is a well-characterised cytoskeletal protein which regulates cell shape and migration by cross-linking with actin. Filamin A mutations cause a number of human developmental disorders, many of which exhibit skeletal dysplasia. However, the molecular mechanisms by which Filamin A affects skeletal development are unknown. The transcription factor Runx2 is a master regulator of osteoblast and chondrocyte differentiation. Data presented in this thesis show that Filamin A forms a complex with Runx2 in osteoblastic cell lines. Moreover, it is demonstrated that Filamin A is present in the nucleus in several cell lines, including those of osteoblastic origin. The data presented show that the Filamin A/Runx2 complex suppresses the expression of the gene encoding the matrix-degrading enzyme, matrix metalloproteinase-13 (MMP-13), which is an important osteoblastic differentiation marker. ChIP assays were employed to demonstrate that endogenously expressed Filamin A associates with the promoter of the MMP-13 gene. In addition, Filamin A is not only located in the nucleus but also in the nucleolus, an important nuclear compartment involved in ribosomal RNA (rRNA) transcription. Ribosomal DNA promoter-driven reporter assays, Filamin A-knockdown experiments and exogenous Filamin A transfections demonstrated that Filamin A and Runx2 can repress ribosomal gene expression activity. Importantly, Filamin A is recruited to the human ribosomal DNA promoter, suggesting its direct involvement in the regulation of rRNA transcription. These findings reveal a novel role of Filamin A in the direct regulation of ribosomal gene expression. Finally, by using microarray technology, changes in gene expression were identified when Filamin A was downregulated. Some of the differentially expressed genes were known orchestrators of bone development. The data presented in this thesis strengthen the link between Filamin A and bone development and provide a molecular rationale for how Filamin A, acting as a regulator of gene expression, might influence osteoblastic differentiation.

京都大学 / 0048 / 新制・課程博士 / 博士(医学) / 甲第19569号 / 医博第4076号 / 新制||医||1017(附属図書館) / 32605 / 京都大学大学院医学研究科医学専攻 / (主査)教授 江藤 浩之, 教授 武藤 学, 教授 中畑 龍俊 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

In the United States, nearly half a million bone graft operations are performed annually to repair defects arising from birth defects, trauma, and disease, making bone the second most transplanted tissue. Autogenous bone is the current gold standard for bone grafts; however it is in limited supply and results in a second injury at the donor site. A promising alternative is a tissue engineered bone graft composed of a biomaterial scaffold, pharmaceutics, and osteoprogenitor cells. One source of osteoprogenitor cells is bone marrow stroma, which can be obtained from the patient - minimizing the risk of an immune response - directed in vitro to proliferate, and differentiate into a bone-like tissue. To date, tissue engineered bone grafts have not been clinically effective; thus, strategies must be developed to improve efficacy. I hypothesize that to facilitate tissue healing in a manner similar to autogenous bone tissue engineering bone must possess a mineralized collagen matrix to support tissue integration, and angiogenic factors to stimulate vascular infiltration, and osteogenic factors to direct normal bone remodeling. I propose that these factors can be synthesized by osteoprogenitor cells in vitro when cultured under the appropriate conditions. Previous work has demonstrated that perfusion culture of osteoprogenitor cells within 3D scaffolds stimulates phenotypic markers of osteoblastic differentiation, but those studies did not determine whether the effects were a consequence of shear stress or increased nutrient availability. Consequently, this work has involved studies in a planar geometry, where nutrient effects are negligible. Three studies that characterize the effect of fluid flow on osteoblastic differentiation of osteoprogenitor cells are presented here. The objective of the first study was to determine the effect of shear stress magnitude on cell density and osteocalcin deposition. In this study, radial flow chambers were used to generate a spatially dependent range of shear stresses (0.36 to 2.7 dynes/cm2) across single substrates, and immunofluorescent techniques were used to assay cell phenotype as a function of shear stress. The objective of the second study was to determine the effect of the duration of fluid flow on cell density and phenotypic markers of differentiation. Here, parallel plate flow chambers were used to generate a single shear stress at the cell surface, and entire cell layers were assayed for expression of osteoblastic genes. The objective of the third study was to compare continuous and intermittent fluid flow strategies. In this study, a microprocessor-controlled actuator was added to the flow loop to periodically halt flow, and markers of mechanosensation and osteoblastic differentiation were measured. These studies demonstrated that shear stresses of 0.36 to 2.7 dynes/cm2 stimulate late phenotypic markers of osteoblastic differentiation but not cell proliferation. In addition, this osteogenic effect is sensitive to duration of fluid flow but insensitive to the magnitude of shear stress. Further, intermittent fluid flow enhances cell retention, biochemical markers of mechanotransduction, and synthesis of the angiogenic factor vascular endothelial growth factor (VEGF). Thus, these studies suggest that intermittent fluid flow may be an attractive component of a biodynamic bioreactor for in vitro manufacture of clinically effective tissue engineered bone grafts. Future studies will further investigate intermittent fluid flow strategies and three-dimensional studies with scaffolds suitable for bone tissue engineering. / Ph. D.

Bone is the second most transplanted tissue after blood and the need for bone graft materials continues to rise at an average annual growth rate of over 18%. An engineered bone substitute consisting of a bone-like extracellular matrix deposited on the internal pores of a resorbable biomaterial scaffold is postulated to stimulate normal bone remodeling when implanted in vivo. Part one of this engineering strategy, the deposition of bone-like extracellular matrix, can be achieved by the directed differentiation of progenitor cells such as bone marrow stromal cells (BMSCs). Part two of the engineering strategy, the biomaterial scaffold, can be fabricated with the appropriate mechanical properties using a synthetic polymer system with tunable properties like polyurethanes. Finally, BMSCs seeded within the biomaterial scaffold can be cultured in a perfusion flow bioreactor to stimulate osteoblastic differentiation and the deposition of bioactive factors. Using the three-part engineering strategy described, I hypothesize that the extracellular matrix produced by BMSCs can be modulated by two stimuli: the stiffness of the scaffold and perfusion flow. First, I propose that culturing BMSCs on polyurethane scaffolds with increasing stiffness will increase markers of osteoblastic differentiation. Secondly, I suggest that mechanically stimulating BMSCs with novel perfusion strategies will also increase markers of osteoblastic differentiation. In aim 1, a family of segmented degradable poly(esterurethane urea)s (PEUURs) were synthesized. The modulus of the PEUUR materials was systematically increased from 0.18 to 0.80 MPa by systematically increasing the molecular weight of the poly(ε-caprolactone) (PCL) soft segment from 1425 to 2700 Da. BMSCs were cultured on both rigid polymer films and on porous foam scaffolds to dissociate the effect of variation in polymer chemistry from the effect of scaffold modulus on cell phenotype. These studies demonstrated changes in osteoblastic differentiation as measured by prostaglandin E2 production, alkaline phosphatase activity (ALP) activity, and osteopontin gene expression. However, the increased levels of these phenotypic markers on the PCL 2700 material could not be attributed to scaffold chemistry or modulus. Instead, the differences may be related to polymer crystallinity or surface topography. In aim 2, novel dynamic perfusion strategies were used to investigate the influence of frequency on osteoblastic differentiation. BMSCs were seeded on porous foam scaffolds and exposed to both steady perfusion and pulsatile perfusion at 0.017, 0.050, and 0.083 Hz frequencies. The data presented here demonstrated that while some markers of osteoblastic phenotype such as ALP activity are enhanced by 0.05 Hz pulsatile flow over continuous flow, they are insensitive to frequency at low frequencies. Therefore, future studies will continue to investigate the effect of a larger range of frequencies. Additionally, fluid flow has also been shown to stimulate the deposition of bioactive factors such as BMP-2 and VEGF-A, and these growth factors are known to significantly enhance healing in bone defect models. Therefore, we plan to investigate the effect of dynamic flow strategies on the deposition of these bioactive factors. We propose that an engineered bone graft material containing a bone-like extracellular matrix and producing these growth factors will show more rapid formation of bone when implanted in vivo. / Ph. D.

A osteorradionecrose é uma séria e debilitante consequência da radioterapia da cabeça e pescoço, definida como uma área óssea que não sofre reparação após a irradiação. O objetivo deste trabalho foi analisar o efeito in vivo da presença de células mesenquimais da medula óssea carreadas em gel em defeitos provocados na calvária de ratos submetidos a um modelo experimental de osteorradionecrose. Foi realizada a obtenção de células osteoblásticas da medula óssea de ratos cultivadas in vitro e devidamente caracterizadas quanto ao seu fenótipo por meio de ensaios bioquímicos como proliferação celular, atividade de fosfatase alcalina e sua detecção in situ, além da detecção e quantificação de nódulos mineralizados. Posteriormente, ratos wistar foram submetidos ao protocolo de osteorradionecrose (irradiação com 20 Gy em dose única) e pareados com controles para em seguida serem realizados defeitos nas calvárias para inserção de células osteoblásticas da medula óssea previamente cultivadas in vitro juntamente com gel carreador e realizada a sutura. Os animais foram divididos em 4 grupos: controle (C), controle + células osteoblásticas (CC); osteorradionecrose (IR) osteorradionecrose + células osteoblásticas (IRc). Ao final de 4 semanas os animais foram sacrificados e realizados os seguintes ensaios: (1) análise histológica com base em cortes histológicos descalcificados (2) análise tomográfica por meio de micro-CT dos defeitos previamente criados. Os dados obtidos foram submetidos ao teste de normalidade e posteriormente à análise estatística para p<0,05. As células mesenquimais derivadas da medula óssea apresentaram fenótipo característico de células osteoblásticas após serem cultivadas em meio osteogênico, com aumento da proliferação, atividade de fosfatase alcalina e formação de nódulos mineralizados quando comparado com as células cultivadas em meio basal. A análise qualitativa dos cortes histológicos corados em hematoxilina-eosina e tricrômico de Masson demonstrou maior neoformação óssea no grupo IRc quando comparado ao grupo IR e similar ao grupos controles. A análise tomográfica revelou um aumento na espessura trabecular, densidade de conectividade, número trabecular e superfície óssea no grupo IRc em relação ao grupo IR. Os resultados sugerem que a inserção de células mesenquimais diferenciadas em osteoblastos favorece a neoformação de defeitos ósseos na presença de osteorradionecrose. / Osteoradionecrosis is a serious and debilitating consequence of head and neck radiotherapy, defined as a bone area that does not repair after irradiation. The purpose of this investigation was to analyze in vivo the presence of mesenchymal cells from bone marrow in calvariae defects of rats submitted to osteoradionecrosis. Cells were collected from rat femur bone marrow to perform characterization of osteoblastic phenotype by means of biochemical assays such as cell proliferation, alkaline phosphatase activity and its in situ detection and mineralization. Afterwards, male wistar rats were submitted to osteoradionecrosis protocol (20 Gy in a single dose) and paired with control animals. After 30 days, there were performed calvariae defects and placement of osteoblastic cells previously cultured with a gel vehicle inside the defects, which were sutured properly. The animals were divided in 4 groups: control (C), control + osteoblastic cells (CC), osteoradionecrosis (IR) osteoradionecrosis + osteoblastic cells (Irc). After 30 days, the animals were euthanized to perform the following analysis: (1) Histological evaluation by means of decalcified slide sections stained with hematoxilin-eosin and Masson trichrome; (2) Tomographic evaluation by means of adequate parameters. Data obtained were submitted to normality test and statistical analysis for p<0,05. The mesenchymal cells from bone marrow presented osteoblastic phenotype after being cultured in osteogenic medium, with higher ALP detection and activity, as well as an increase of mineralized nodules when compared to cells cultured in basal medium. Histological analysis showed that irradiation impaired bone neoformation and affected bone marrow composition, as well as the presence of osteoblasts and osteocytes. On the other hand, cell therapy in group IRc improved bone neoformation when compared to group IR, showing similarity to control groups. Tomographic analysis revealed an increase in trabecular thickness, density of connectivity, trabecular number and bone surface when compared to group IR. The results suggest that the placement of mesenchymal cells differentiated in osteoblasts may improve bone neoformation of defects created after the onset of osteoradionecrosis.

Os eventos celulares e extracelulares que ocorrem durante o processo de osseointegração do titânio (Ti) são influenciados pelas propriedades físicas e químicas de sua superfície. Modificações bioquímicas de topografias complexas de Ti permitem o desenvolvimento de novas superfícies de implantes funcionalizadas com moléculas bioativas, visando a promover a osteogênese de contato e a osseointegração. O objetivo do presente estudo foi avaliar os efeitos, sobre a osteogênese in vitro, da funcionalização de microtopografia de Ti com concentrações distintas de peptídeo sintético análogo a uma seqüência de amino-ácidos do colágeno tipo I, relacionada a adesão e diferenciação celulares. Células osteogênicas primárias derivadas de calvárias de ratos foram plaqueadas sobre superfícies de Ti: 1) usinada e lixada (Usinado); 2) com microtopografia (Plus); 3) Plus com recobrimento de hidroxiapatita (Plus+HA); 4) Plus+HA, com baixa concentração de P-15 (P-15 low); 5) Plus+HA, com alta concentração de P-15 (P-15 high). Por períodos de até 21 dias, foram avaliados: morfologia celular e estágios de adesão e espraiamento celulares; viabilidade celular, proporção de células no ciclo celular e número total de células; imunolocalização de proteínas da matriz extracelular não-colágena; expressão de marcadores do fenótipo osteoblástico por reação em cadeia da polimerase em tempo real (Real-time PCR); atividade de fosfatase alcalina (ALP); proporção de células em apoptose e formação de matriz mineralizada. Avaliaram-se, também, os aspectos topográficos das superfícies, por microscopia eletrônica de varredura (MEV) de alta resolução, e o molhamento de superfície, pelo método da gota séssil. As superfícies Plus modificadas apresentavam camada superficial constituída por agregados de material acicular, os quais eram menos evidentes em P-15 high. Todas as superfícies eram hidrofóbicas, sendo que a funcionalização com P-15 proporcionava tendência à hidrofilicidade em equilíbrio. Após 4 h, observou-se que as superfícies com microtopografia apresentavam menor proporção de células nos estágios 3 e 4 de espraiamento quando comparadas com o Usinado (p<0,05). A viabilidade celular por MTT demonstrou valores maiores para as superfícies Plus modificadas aos 3 dias (p<0,05). Em 1 dia, acúmulos extracelulares de osteopontina (OPN) foram evidentes apenas sobre Plus+HA, P-15 low e P-15 high, com maior extensão em 3 dias. Em 7 dias, áreas imunomarcadas para sialoproteína óssea (BSP) eram menos extensas sobre Plus e Plus+HA. Para os grupos com microtopografia, foram observados valores de RNAm: menores para RUNX2 em 7 dias em comparação ao Usinado; para fosfatase alcalina (ALP), maiores em 10 se comparados a 7 dias; menores para BSP e maiores para OPN em 7 e 10 dias, quando comparados ao Usinado. Em 10 dias, observou-se redução significante (p<0,05) na atividade de ALP nas superfícies com microtopografia em comparação ao Usinado. Aos 14 dias, formações nodulares típicas de matriz mineralizada, marcadas para BSP em sua periferia, foram observadas apenas nos grupos Usinado e Plus. No entanto, a quantificação do vermelho de Alizarina (ARS) revelou valores maiores para as culturas sobre superfícies Plus modificadas em 14 e 21 dias (p<0,05). Concluiu-se que a microtopografia de Ti Plus, nanoestruturada com HA para funcionalização de P-15, altera o processo de aquisição do fenótipo osteogênico in vitro, resultando no aumento da formação de matriz calcificada, em padrão predominantemente diferente ao de típicas formações nodulares observadas sobre superfícies planas na microescala. / Surface functionalization of metallic surfaces with bioactive molecules has been developed aiming to promote specific cellular response at biomaterial-tissue interface. The present study evaluated the effects of surface functionalization of a microstructured titanium (Ti) surface with a synthetic peptide (P-15) analogue of the cell-binding domain of collagen I on key parameters of the progression of the osteogenic phenotype in vitro. Calvaria-derived osteogenic cells were plated on Ti disks: i) Machined; ii) with microtopography (Plus); iii) Plus with hydroxyapatite coating (Plus+HA); iv) Plus+HA with a low concentration of P-15 (P-15 low); v) Plus+HA with a high concentration of P-15 (P-15 high). High resolution SEM analysis showed that Plus exhibited a complex microtopography. In addition, a superficial layer of nano-sized needle-shaped HA was noticed for all modified Plus surfaces, although less apparent for P-15 high. Whereas all surfaces were hydrophobic at time zero, biofunctionalization showed a tendency to hydrophilicity at equilibrium. At 4 hours, Plus and modified Plus surfaces exhibited a lower proportion of spread osteogenic cells. At day 3, cells were less spread on the microtopographies, showing long cytoplasmic extensions. Epifluorescence revealed a large extracellular OPN accumulation for modified Plus surfaces. Although at day 3 cell viability was higher for modified Plus surfaces, at day 7 no major differences were detected among groups. Real time PCR showed for Plus and modified Plus surfaces: i) lower levels for RUNX2 at day 7 and for BSP at days 7 and 10, and higher OPN levels at days 7 and 10 compared with Machined; ii) higher ALP levels at day 10 compared with day 7. At day 10, Plus and modified Plus surfaces showed lower ALP activity compared with Machined. At days 14 and 21, higher proportions of Alizarin red stained areas were detected for cultures grown on modified Plus surfaces. The modification of Ti Plus surface by means of HA coating and functionalization with peptide P-15 alters the osteogenic potential of osteoblastic cell cultures, leading to an enhancement in mineralized matrix formation.

Estudos sugerem que a cafeína atua sobre o osso promovendo aumento da excreção de cálcio e inibição da proliferação de osteoblastos, aumentando o risco de fraturas, osteoporose e doença periodontal. Os efeitos da cafeína sobre o tecido ósseo dificultam a aplicação de implantes dentários devido à presença de grandes defeitos ósseos ou volume ósseo insuficiente. Vários métodos são propostos para a regeneração de defeitos ósseos, entre eles, o uso de diferentes tipos de enxertos, os quais demonstram capacidade em promover a formação óssea A despeito das desvantagens, o osso autógeno ainda é considerado a referência padrão como enxerto ósseo, devido ao seu potencial osteogênico, osteoindutor e osteocondutor. A engenharia tecidual óssea tem sido utilizada como uma estratégia para a regeneração óssea. As células tronco mesenquimais são consideradas multipotentes e podem replicar como células indiferenciadas, possuindo potencial para se diferenciarem em linhagens de osso, cartilagem, gordura e cartilagem. O objetivo deste estudo foi quantificar histomorfometricamente a reparação óssea pelo enxerto de uma associação de osso autógeno obtido da calota craniana e células osteoblásticas em defeitos ósseos produzidos pela extração dental de ratos submetidos à administração diária de cafeína. Os animais foram divididos em: Controle (c), osso autógeno (oa) e osso autógeno + células osteoblásticas (oa+co) e receberam injeções diárias intraperitonealmente de 30 mg/kg/dia de cafeína durante trinta dias, os homólogos receberam de solução salina. Os ratos foram sacrificados nos períodos de 7, 21 e 42 dias pós-cirurgia e as amostras teciduais foram processadas para a obtenção de secções finas (5 m) e coradas com HE. Através de um sistema de análise de imagens se estimou a fração de volume de osso, conjuntivo e coágulo, no defeito ósseo. Os resultados histológicos e histométricos mostraram que nos animais sob tratamento com cafeína houve uma menor formação óssea estatisticamente significante a 1%, e um retardo na reabsorção do coágulo sanguíneo quando comparado aos alvéolos dos animais sob tratamento com soro fisiológico. A análise qualitativa do fragmento de osso autógeno isoladamente ou associado às células osteoblásticas mostrou uma osteointegração progressiva e sem reação de corpo estranho nos animais tratados com soro fisiológico e, as células implantadas não propiciaram reações imunogênicas nem a formação tumoral, possibilitando um aumento (25%) na reparação óssea dos animais tratados com a cafeína. Conclui-se que o enxerto/implante das células osteoblásticas associadas ao osso autógeno da calota craniana foi capaz de compensar, nos períodos tardios, os efeitos deletérios da cafeína na reparação óssea alveolar. / Studies suggest that caffeine acts on the bone for increasing the excretion of calcium and inhibition of osteoblasts proliferation, increasing the risk of fractures, osteoporosis and periodontal disease. The effects of caffeine on bone difficult the application of dental implants due to large bone defects and insufficient bone volume. Several methods are proposed for the regeneration of bone defects, including the use of different types of grafts, which show ability to promote bone formation. Despite the disadvantages, the autogenous bone is still considered the gold standard as bone graft because the potential osteogenic, osteoinductive and osteoconductive. The bone tissue engineering has been used as a strategy for bone regeneration. The mesenchymal stem cells are considered multipotent and can replicate as undifferentiated cells, with potential to differentiate into lineages of bone, cartilage, fat and cartilage. This study aimed to quantify histomorphometrycally bone repair by grafts of a combination of autogenous bone obtained from the skull and osteoblastic cells in bone defects produced by dental extraction in rats subjected to daily administration of caffeine. The animals were divided into: Control (c), autogenous bone (ab) and autogenous bone + osteoblastic cells (ab + oc) and received daily injections intraperitoneally of 30 mg/kg/day of caffeine for thirty days, the counterparts received saline solution. The rats were sacrificed at times of 7th, 21st and 42nd days post-surgery and tissue samples were processed to obtain thin sections (5 m) and stained with HE. Through an image analysis system was estimated the fraction of volume of bone, collagen and blood clot in the bone defect. The histological and histometric results showed that in animals under treatment with caffeine had a lower bone formation statistically significant at 1%, and a delay in the resorption of blood clots when compared to the alveoli of animals under treatment with saline. The qualitative analysis of the fragment of autogenous bone alone or associated with osteoblastic cells showed a progressive osteointegration and no foreign body reaction in animals treated with saline, and implanted the cells not provided immunogenic reactions or tumor formation, allowing an increase (25%) on bone repair in animals treated with caffeine. It was concluded that the graft/implant of osteoblastic cells associated with autogenous bone from the skull was able to compensate in later periods, the deleterious effects of caffeine on alveolar boné repair.